Jump to main content
Jump to site search

Issue 32, 2016
Previous Article Next Article

Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion

Author affiliations

Abstract

A new series of novel 1-phenanthryl-tetrahydroisoquinoline derivatives were designed, synthesized and biologically evaluated for their PAK4 inhibitory activities and anti-proliferative effects against three cancer cell lines A549, MCF-7 and HT-1080. Among them, compound 12a exhibited the most potent inhibitory activity against PAK4 with an IC50 value of 0.42 μM. Moreover, this compound inhibited the invasion of A549 tumor cells by regulating the PAK4–LIMK1–cofilin signaling pathway in vitro, and exhibited anti-tumor activity in vivo in the A549 tumor xenograft model. To further evaluate the binding mode of 12a with PAK4, the biotinylated 12a derivative has been synthesized and it was used for immunoprecipitation assay. Intriguingly, our observations suggest that 12a interacts with both the N- and C-termini of PAK4.

Graphical abstract: Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion

Back to tab navigation

Supplementary files

Publication details

The article was received on 17 May 2016, accepted on 15 Jul 2016 and first published on 15 Jul 2016


Article type: Paper
DOI: 10.1039/C6OB01072E
Author version
available:
Download author version (PDF)
Org. Biomol. Chem., 2016,14, 7676-7690

  •   Request permissions

    Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion

    C. Hao, X. Li, S. Song, B. Guo, J. Guo, J. Zhang, Q. Zhang, W. Huang, J. Wang, B. Lin, M. Cheng, F. Li and D. Zhao, Org. Biomol. Chem., 2016, 14, 7676
    DOI: 10.1039/C6OB01072E

Search articles by author

Spotlight

Advertisements